We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

62 hedge funds and large institutions have $226M invested in Foghorn Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

65,000% more call options, than puts

Call options by funds: $651K | Put options by funds: $1K

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 60 → 62 (+2)

6% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 17

0.18% less ownership

Funds ownership: 63.36% → 63.18% (-0.18%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

37% less capital invested

Capital invested by funds: $357M → $226M (-$132M)

Holders
62
Holders Change
+2
Holders Change %
+3.33%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
8
Increased
18
Reduced
17
Closed
6
Calls
$651K
Puts
$1K
Net Calls
+$650K
Net Calls Change
+$648K

Top Buyers

1
RWM
Rockwood Wealth Management
Pennsylvania
+$1.6M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$908K
3
Citadel Advisors
Citadel Advisors
Florida
+$871K
4
Victory Capital Management
Victory Capital Management
Texas
+$483K
5
TI
Trexquant Investment
Connecticut
+$286K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$2.39M
2
DCM
Driehaus Capital Management
Illinois
-$681K
3
BlackRock
BlackRock
New York
-$341K
4
DTL
Dynamic Technology Lab
Singapore
-$279K
5
BC
Birchview Capital
Vermont
-$257K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$213K +$21.9K +1,701 +7%
TI
27
Trexquant Investment
Connecticut
$190K +$286K +22,197 New
Goldman Sachs
28
Goldman Sachs
New York
$145K +$7K +544 +3%
TF
29
TIAA FSB
Florida
$124K – – –
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$117K +$541 +42 +0.3%
MIM
31
MetLife Investment Management
New Jersey
$117K – – –
State Board of Administration of Florida Retirement System
32
State Board of Administration of Florida Retirement System
Florida
$107K – – –
HF
33
HRT Financial
New York
$101K -$75.5K -5,866 -33%
JP Morgan Chase
34
JP Morgan Chase
New York
$94K +$3.04K +236 +2%
FT
35
Fiduciary Trust
Massachusetts
$93K – – –
HSBC Holdings
36
HSBC Holdings
United Kingdom
$92K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$91.9K +$138K +10,707 New
WS
38
Wedbush Securities
California
$91K +$5.69K +442 +4%
NC
39
NewSquare Capital
Pennsylvania
$86K – – –
AIG
40
American International Group
New York
$82K +$1.74K +135 +1%
Bank of America
41
Bank of America
North Carolina
$78K -$27.8K -2,163 -19%
Deutsche Bank
42
Deutsche Bank
Germany
$73K -$17.3K -1,345 -14%
VEA
43
Virtus ETF Advisers
New York
$71K +$772 +60 +0.7%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$68K -$8.51K -661 -8%
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$37K +$56.1K +4,360 New
TRCT
46
Tower Research Capital (TRC)
New York
$31K +$22.7K +1,767 +92%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$29K +$1.7K +132 +4%
AB
48
Amalgamated Bank
New York
$27K +$631 +49 +2%
Legal & General Group
49
Legal & General Group
United Kingdom
$19K – – –
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$13.9K – – –
1
2
3

FHTX Hedge Fund Activity: Q3 2022 in Review

62 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q3 2022, worth a combined $226M — down 37% from $357M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FHTX positions and 6 closed out — a net gain of 2 holders — while 18 added to existing stakes and 17 trimmed.

The largest buyer was Rockwood Wealth Management, opening a new position worth an estimated $1.6M. The largest seller was Morgan Stanley, cutting an estimated $2.39M.

  • 62 institutional investors held Foghorn Therapeutics (FHTX) as of Q3 2022, up from 60 in Q2 2022.
  • Funds reported $226M of Foghorn Therapeutics stock for Q3 2022, down 37% quarter-over-quarter.
  • 8 funds opened new Foghorn Therapeutics positions in Q3 2022 and 6 closed out, a net change of +2 holders.
  • The largest Foghorn Therapeutics buyer in Q3 2022 was Rockwood Wealth Management, an estimated $1.6M added.
  • The largest Foghorn Therapeutics seller in Q3 2022 was Morgan Stanley, an estimated $2.39M sold.

Based on aggregated 13F filings for Q3 2022.